327.a Cardiac xenotransplantation in humans: Lessons learned and path forward
Prof. Muhammad Mohiuddin, United States
327.1 Xenotransplantation cures diabetes using local immunosuppression to protect transgenic porcine neonatal islet cell xenografts in the diabetic baboon model
Wayne Hawthorne, Australia
327.2 The concern of HLA-class Ib on natural immunity, especially neutrophil
Shuji Miyagawa, Japan
327.3 Differential expression of human xenoantibodies to wt and GalT-KO pig endothelial cells after patients exposure to pig hepatocytes following BAL Treatment
Prof. Angeles Baquerizo, United States
327.4 Long-term survival in pig-to-NHP kidney xenotransplantation with clinically relevant calcineurin inhibitor-based immunosuppression
Prof. Kazuhiko Yamada, United States
327.5 10GE pig-to-baboon lung xenotransplantation, combined with immunosuppressive therapy and pharmacologic treatment
Ms. Sara De Taeye, United States
327.6 Reduced inflammation and lymphocyte infiltration after reperfusion in triple knock-out porcine kidney xenografts expressing human transgenes transplanted to nonhuman primates
Dr. Ahmad Karadagi, United States
327.7 Multi-omics Profiling in Human Decedents Receiving Genetically Modified Pig Hearts Reveals Hallmarks of Perioperative Cardiac Xenograft Dysfunction.